HRMY EBITDA Growth
Harmony Biosciences Hldg Inc · EBITDA Growth
HRMY EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported4.28%period ending
HRMY TTM EBITDA YoY % (118.27% → 4.28%)
Year-over-year change
High-resolution chart · PNG
HRMY ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 4.2781% | |
| -1.9391% | |
| 7.7181% | |
| 16.5103% | |
| 20.0468% | |
| -2.8839% | |
| 0.5453% | |
| 1.6327% | |
| 24.2294% | |
| 52.5984% | |
| 61.5041% | |
| 131.0159% | |
| 125.5234% | |
| 137.3843% | |
| 165.8062% | |
| 64.9456% | |
| 9.8724% | |
| 27.6357% | |
| 107.3902% | |
| 430.9588% | |
| 221.7494% | |
| 160.657% | |
| 118.2735% |